This result suggests that apart from resistance Selumetinib nmr due to carbapenemase producing genes in A. baumanii isolates, some other mechanisms also works for carbapenem resistance which may be efflux overexpression or membrane impermability. Current study had a limitation of not evaluating the reasons for differences observed in phenotypic and gentotypic resistance in MDR A. baumanii and need further evaluation of these strains. The concern over pan drug resistant bacteria warrants surveillance on a large scale and need of newer antibiotics. The antimicrobial susceptibility trend of novel Antibiotic

Adjuvant Entity, Elores revealed that it was the most active antibiotic on majority of carbapenemase producing A. baumannii strains isolated from the lower respiratory tract (LRTI) specially catheter based infections which might be due to formation of biofilm disruption by Elores. 25 On the other hand, the rates of reduced susceptibility to multidrug resistant carbapenemase producing A. baumanii were observed

in catheter based LRTI infection more often of intermediate susceptibility or resistant to penems, piperacillin plus tazobactam and colistin than this website meningitis, sepsis and other infections. The enhanced susceptibility of ceftriaxone plus disodium edetate plus sulbactam (Elores) against A. baumannii is likely to be associated with synergistic activity of ceftriaxone plus sulbactam plus disodium edetate. Disodium edentate, a non antibiotic adjuvant, present in Elores chelates the divalent metal ions particularly zinc thus de-activating the carbapenemase and enhancing activity against carbapenemase producing organisms synergistically. why We observed that none of the isolates was found to be susceptible to beta-lactam and beta-lactamase inhibitor combination. Our results revealed that penems (doripenem, imipenem and meropenem) exhibited alarmingly high (71–91%) resistant to carbapenemase producing A. baumannii isolates which was similar to a study conducted by Muthusamy and Boppe 6 who demonstrated imipenem and meropenem resistance to be approximately 100% in A. baumannii.

The major findings of the study were that the overall prevalence of Acinetobacter, including multidrug resistant carbapenemase producing Acinetobacter strains, increased during the study period and is associated with substantial morbidity and mortality due to frequent treatment failures. Newer options like novel antibiotic adjuvant entity Elores appeared promising safer solution in comparison to colistin (a known toxic agent). However, this study had a few limitations like data could not be correlated to the patient age and other complications. We conclude that the incidence of high rates of resistance and reduced susceptibility to penems and piperacillin plus tazobactam is alarming high and is continuously increasing and spreading.